Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$19,400,052
+$1,328,660 QoQ
Shares Held
123,788
+4.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#123
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rockefeller Capital Management L.P. holds $1,983,048,474 across 16 Drug Manufacturers - General names. NVS ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
559,339 | $670,888,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,137,643 | $288,927,190 | |
| 3 | ABBV |
AbbVie Inc.
|
980,805 | $246,809,766 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,848,360 | $237,514,257 | |
| 5 | AMGN |
Amgen Inc
|
636,122 | $230,352,496 | |
| 6 | AZN |
Astrazeneca PLC
|
467,619 | $88,669,912 | |
| 7 | NVO |
Novo Nordisk A S
|
1,566,451 | $75,095,658 | |
| 8 | PFE |
Pfizer Inc
|
1,993,256 | $47,997,600 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,400,052 | 123,788 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $18,071,392 | 118,307 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $14,918,221 | 108,205 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $13,167,554 | 102,679 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,827,879 | 97,743 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $11,333,391 | 101,663 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $10,490,211 | 107,802 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $12,147,605 | 105,613 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,766,277 | 110,523 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $14,387,715 | 148,741 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $10,276,826 | 101,781 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $12,888,446 | 126,531 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $19,861,811 | 196,827 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,747,628 | 192,909 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $19,376,430 | 213,585 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $16,253,064 | 213,828 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $18,119,257 | 214,353 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,662,231 | 201,279 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $19,553,480 | 223,545 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,177,070 | 210,040 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $18,327,012 | 200,866 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $11,395,593 | 133,313 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $9,832,711 | 104,127 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $13,164,959 | 151,391 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $77,898,981 | 891,905 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $96,397,240 | 1,169,160 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||